We are live on ! Find out more
Commonwealth Equity Services

Commonwealth Equity Services Portfolio holdings

AUM $71.6B
1-Year Est. Return 21.08%
This Fund
S&P 500
This Quarter Est. Return
-3.27%
1 Year Est. Return
+21.08%
3 Year Est. Return
+64.42%
5 Year Est. Return
+73.55%
10 Year Est. Return
+239.11%
AUM
$43.7B
AUM Growth
-$654M
Cap. Flow
+$1.55B
Cap. Flow %
3.54%
Top 10 Hldgs %
18.76%
Holding
3,868
New
224
Increased
1,970
Reduced
1,386
Closed
163

Sector Composition

Rank Sector Weight
1 Technology 11.86%
2 Financials 5.98%
3 Healthcare 4.98%
4 Consumer Discretionary 4.84%
5 Industrials 3.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CARM
3626
DELISTED
Carisma Therapeutics
CARM
$29K ﹤0.01%
2,471
+750
+44% +$10.5K
LXRX icon
3627
Lexicon Pharmaceuticals
LXRX
$1.02B
$29K ﹤0.01%
14,276
IVR icon
3628
Invesco Mortgage Capital
IVR
$776M
$28K ﹤0.01%
1,228
-1,095
-47% -$26.9K
PLG
3629
Platinum Group Metals
PLG
$164M
$28K ﹤0.01%
+13,589
New +$26.3K
MILE
3630
DELISTED
Metromile, Inc. Common Stock
MILE
$28K ﹤0.01%
21,355
-1,000
-4% -$1.45K
CRNT icon
3631
Ceragon Networks
CRNT
$194M
$27K ﹤0.01%
12,985
+10
+0.1% +$22
PEI
3632
DELISTED
Pennsylvania Real Estate Investment Trust
PEI
$27K ﹤0.01%
2,860
-800
-22% -$10.7K
ASM
3633
Avino Silver & Gold Mines
ASM
$987M
$26K ﹤0.01%
28,000
CLRB icon
3634
Cellectar Biosciences
CLRB
$19.3M
$25K ﹤0.01%
123
HOFV
3635
DELISTED
Hall of Fame Resort & Entertainment Co
HOFV
$25K ﹤0.01%
1,024
-318
-24% -$8.18K
VTGN icon
3636
VistaGen Therapeutics
VTGN
$9.29M
$25K ﹤0.01%
690
APTX
3637
DELISTED
Aptinyx Inc. Common Stock
APTX
$25K ﹤0.01%
11,100
TMDI
3638
DELISTED
Titan Medical Inc. Ordinary Shares
TMDI
$25K ﹤0.01%
47,982
+16
+0% +$9
LITS
3639
Lite Strategy Inc
LITS
$33.6M
$24K ﹤0.01%
2,005
PAVM icon
3640
PAVmed
PAVM
$33.9M
$24K ﹤0.01%
+41
New +$30.5K
LOGC
3641
DELISTED
ContextLogic
LOGC
$24K ﹤0.01%
+358
New +$25.3K
BSFC
3642
DELISTED
Blue Star Foods Corp. Common Stock
BSFC
$24K ﹤0.01%
13
MTNB icon
3643
Matinas BioPharma
MTNB
$1.55M
$23K ﹤0.01%
580
VZLA
3644
Vizsla Silver
VZLA
$1.16B
$23K ﹤0.01%
+11,817
New +$23.9K
TPHS
3645
DELISTED
Trinity Place Holdings Inc.com
TPHS
$23K ﹤0.01%
12,502
CFMS
3646
DELISTED
Conformis, Inc. Common Stock
CFMS
$23K ﹤0.01%
1,516
+200
+15% +$3.29K
SLNO
3647
DELISTED
Soleno Therapeutics
SLNO
$22K ﹤0.01%
+6,667
New +$34.5K
SEEL
3648
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
$22K ﹤0.01%
7
NBEV
3649
DELISTED
NewAge, Inc. Common Stock (Delaware)
NBEV
$22K ﹤0.01%
38,093
-3,000
-7% -$2.15K
ANY icon
3650
Sphere 3D
ANY
$14.6M
$21K ﹤0.01%
147
-63
-30% -$10.2K

Similar funds

Commonwealth Equity Services's Q1 2022 Portfolio in Review

As of Q1 2022, Commonwealth Equity Services held 3,868 positions worth $43.7B, down 1.5% from $44.4B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Commonwealth Equity Services deployed $1.55B of net new capital in Q1 2022, opening 224 new positions and adding to 1,970 existing holdings. Its largest new stake was Shell: 319,280 shares worth $17.5M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 13% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Vanguard Total International Bond ETF, an estimated $51.8M trimmed.

  • Commonwealth Equity Services's largest Q1 2022 buy was Shell: 319,280 shares worth $17.5M.
  • Commonwealth Equity Services added most to iShares Core S&P 500 ETF in Q1 2022, an estimated $55.2M increase.
  • Commonwealth Equity Services's biggest Q1 2022 reduction was Vanguard Total International Bond ETF, cutting an estimated $51.8M.
  • Commonwealth Equity Services fully exited Xilinx Inc in Q1 2022, selling an estimated $8.28M.
  • Commonwealth Equity Services's ten largest holdings make up 19% of its $43.7B portfolio in Q1 2022.
  • Commonwealth Equity Services opened 224 new positions and closed 163 in Q1 2022.
  • Commonwealth Equity Services's portfolio value fell 1.5% quarter-over-quarter to $43.7B.

Based on Commonwealth Equity Services's 13F filing for Q1 2022, filed 4 May 2022.